Pharmaceutical - UK, Financial

Filter

Current filters:

UKFinancial

Popular Filters

GW Pharma shows drop in revenue but expects ‘steady progress’

GW Pharma shows drop in revenue but expects ‘steady progress’

07-05-2014

UK-based GW Pharmaceuticals, a biopharmaceutical company focused on developing novel therapeutics from…

FinancialGW PharmaceuticalsNeurologicalPharmaceuticalSativexUK

UK Pharma moves on transparency of financial relationships with health professionals

03-04-2014

The UK’s pharmaceutical industry today announced another step towards greater transparency by revealing…

FinancialNorthern EuropePharmaceuticalResearchUK

Pharma Summit: AIDS activists picket to demand South African reform

Pharma Summit: AIDS activists picket to demand South African reform

14-03-2014

Delegates at The Economist’s Pharma Summit in London yesterday were greeted by AIDS activists picketing…

Anti-viralsFinancialLegalPharmaceuticalPricingSouth AfricaUK

Merck Serono’s Erbitux to be funded by CDF in England for mCRC

28-02-2014

The UK’s Cancer Drugs Fund (CDF) says that Erbitux (cetuximab) can be used in the first line setting…

ErbituxFinancialHealthcareMerck KGaAMerck SeronoNorthern EuropeOncologyPharmaceuticalUK

NHS England approves GSK’s Tafinlar for funding by UK’s Cancer Drugs Fund

NHS England approves GSK’s Tafinlar for funding by UK’s Cancer Drugs Fund

04-02-2014

GlaxoSmithKline’s Tafinlar (dabrafenib) is now available for metastatic melanoma patients in England…

FinancialGSKOncologyPharmaceuticalRegulationTafinlarUK

AstraZeneca expects 2017 revenues to be broadly in line with 2013 revenues

AstraZeneca expects 2017 revenues to be broadly in line with 2013 revenues

14-01-2014

Anglo-Swedish drug major AstraZeneca (LSE: AZN) will provide an update on its business plans at the JP…

AstraZenecaFinancialPharmaceuticalUK

UK’s NICE hits back at claims it spent taxpayer money on champagne

UK’s NICE hits back at claims it spent taxpayer money on champagne

13-01-2014

The UK’s National Institute for Health and Care Excellence (NICE) has refuted claims by one of the…

FinancialPharmaceuticalUK

New UK pharma company to target respiratory disease

New UK pharma company to target respiratory disease

11-12-2013

A new biopharmaceutical company has been founded to develop innovative new approaches to treat respiratory…

FinancialPharmaceuticalRespiratory and PulmonaryUK

GW Pharma sees fiscal 2012/3 revenues decline, impacted by Sativex

GW Pharma sees fiscal 2012/3 revenues decline, impacted by Sativex

19-11-2013

UK-based GW Pharmaceuticals (AIM: GWP) which is focused on novel cannaboid therapeutics, has announced…

CNS DiseasesFinancialGW PharmaceuticalsPharmaceuticalSativexUK

BTG reveals six-month revenue up 17% and meets analysts’ expectations

12-11-2013

UK specialist health care company BTG (LSE: BTG) has announced its interim results for the six months…

BTGEuropeFinancialLemtradaOncologyPharmaceuticalTheraSphereUKZytiga

Immunocore makes progress in deal with GSK

Immunocore makes progress in deal with GSK

07-11-2013

UK-based biotech firm Immunocore has achieved its first milestone in its major research and licensing…

EuropeFinancialGlaxoSmithKlineImmunocoreLicensingOncologyPharmaceuticalResearchUK

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top